178 related articles for article (PubMed ID: 16340783)
1. The significance of a single episode of minimal acute rejection after lung transplantation.
Hachem RR; Khalifah AP; Chakinala MM; Yusen RD; Aloush AA; Mohanakumar T; Patterson GA; Trulock EP; Walter MJ
Transplantation; 2005 Nov; 80(10):1406-13. PubMed ID: 16340783
[TBL] [Abstract][Full Text] [Related]
2. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome.
Khalifah AP; Hachem RR; Chakinala MM; Yusen RD; Aloush A; Patterson GA; Mohanakumar T; Trulock EP; Walter MJ
Am J Transplant; 2005 Aug; 5(8):2022-30. PubMed ID: 15996255
[TBL] [Abstract][Full Text] [Related]
3. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
4. Minimal acute rejection in pediatric lung transplantation--does it matter?
Benden C; Faro A; Worley S; Arrigain S; Aurora P; Ballmann M; Boyer D; Conrad C; Eichler I; Elidemir O; Goldfarb S; Mallory GB; Mogayzel PJ; Parakininkas D; Solomon M; Visner G; Sweet SC; Danziger-Isakov LA
Pediatr Transplant; 2010 Jun; 14(4):534-9. PubMed ID: 20059725
[TBL] [Abstract][Full Text] [Related]
5. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
6. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.
Khalifah AP; Hachem RR; Chakinala MM; Schechtman KB; Patterson GA; Schuster DP; Mohanakumar T; Trulock EP; Walter MJ
Am J Respir Crit Care Med; 2004 Jul; 170(2):181-7. PubMed ID: 15130908
[TBL] [Abstract][Full Text] [Related]
7. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
Hadjiliadis D; Davis RD; Palmer SM
Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
[TBL] [Abstract][Full Text] [Related]
8. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
[TBL] [Abstract][Full Text] [Related]
9. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
[TBL] [Abstract][Full Text] [Related]
10. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
13. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.
Fiser SM; Tribble CG; Long SM; Kaza AK; Kern JA; Jones DR; Robbins MK; Kron IL
Ann Thorac Surg; 2002 Apr; 73(4):1041-7; discussion 1047-8. PubMed ID: 11996238
[TBL] [Abstract][Full Text] [Related]
14. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
Finlen Copeland CA; Snyder LD; Zaas DW; Turbyfill WJ; Davis WA; Palmer SM
Am J Respir Crit Care Med; 2010 Sep; 182(6):784-9. PubMed ID: 20508211
[TBL] [Abstract][Full Text] [Related]
15. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches.
van den Berg JW; Hepkema BG; Geertsma A; Koëter GH; Postma DS; de Boer WJ; Lems SP; van der Bij W
Transplantation; 2001 Feb; 71(3):368-73. PubMed ID: 11233895
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
19. Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients.
Hall DJ; Baz M; Daniels MJ; Staples ED; Klodell CT; Moldawer LL; Beaver TM
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):603-7. PubMed ID: 22815323
[TBL] [Abstract][Full Text] [Related]
20. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
